Objective: To determine the prevalence of depressive and anxiety symptoms in patients with rheumatoid arthritis (a chronic inflammatory disease) in comparison to a control group with osteoarthritis (a chronic non-inflammatory degenerative disease) and to identify the sociodemographic and clinical variables associated with depressive symptoms in these patients. Method: Sixty-two rheumatoid arthritis patients and 60 osteoarthritis patients participated in the study. Sociodemographic and clinical data were collected and the Hospital Anxiety and Depression Scale and the Disability Index of the Health Assessment Questionnaire were applied. Results: The prevalence of depressive symptoms was of 53.2% in rheumatoid arthritis and 28.3% in osteoarthritis (p = 0.005). The prevalence of anxiety symptoms was of 48.4% in rheumatoid arthritis and 50.0% in osteoarthritis (p = 0.859). The mean (and standard deviation) scores in the Disability Index of the Health Assessment Questionnaire were 1.4 (0.8) in rheumatoid arthritis and 1.4 (0.6) in osteoarthritis (p = 0.864). Rheumatoid arthritis patients with depressive symptoms had lower education and higher disease activity and functional disability. Conclusion: Although these two rheumatic diseases are similar in terms of the pain and functional disability that they cause, a significantly higher prevalence of depressive symptoms was found in rheumatoid arthritis patients. This difference might be explained by the hypothesis of a neuroimmunobiological mechanism related to cytokines in inflammatory diseases, which has been considered as a candidate to the development of depressive symptoms. Descriptors

A severe impairment of cognitive function characterizes dementia. Mild cognitive impairment represents a transition between normal cognition and dementia. The frequency of cognitive changes is higher in women than in men. Based on this fact, hormonal factors likely contribute to cognitive decline. In this sense, cognitive complaints are more common near menopause, a phase marked by a decrease in hormone levels, especially estrogen. Additionally, a tendency toward worsened cognitive performance has been reported in women during menopause. Vasomotor symptoms (hot flashes, sweating, and dizziness), vaginal dryness, irritability and forgetfulness are common and associated with a progressive decrease in ovarian function and a subsequent reduction in the serum estrogen concentration. Hormone therapy (HT), based on estrogen with or without progestogen, is the treatment of choice to relieve menopausal symptoms. The studies conducted to date have reported conflicting results regarding the effects of HT on cognition. This article reviews the main aspects of menopause and cognition, including the neuroprotective role of estrogen and the relationship between menopausal symptoms and cognitive function. We present and discuss the findings of the central observational and interventional studies on HT and cognition.

No abstract

rESUMo introdução:No contexto da psiquiatria clínica, insight ou crítica da doença é definida como uma subcategoria do autoconhecimento dos pacientes relativa ao reconhecimento das manifestações patológicas que os afetam e também à apreciação das mudanças que tais manifestações causam na sua interação com o mundo. objetivo: Examinar as formas de apresentação do insight na esquizofrenia e em outras psicoses. Métodos: Análise conceitual, com vinhetas clínicas ilustrativas, da relação entre insight e as diversas dimensões sintomatológi-cas da esquizofrenia e condições relacionadas, considerando aspectos clínicos, neurocognitivos, psicodinâmicos e transculturais. resultados: Do ponto de vista conceitual, o construto é conformado pela perspectiva teórica adotada; do ponto de vista clínico, sua apresentação nas psicoses é a resultante da interação com os diferentes domínios sintomatológicos e aspectos subjetivos e culturais do paciente. Conclusão: A avaliação psicopatológica do insight deve levar em conta a complexidade do fenômeno, o recorte teórico em que está situada e a finalidade clínica com que é realizada. aBStraCt introduction: In the context of clinical psychiatry, insight is defined as a subcategory of self-awareness of patients, which is related to the recognition of the pathological manifestations that affect them and also the appreciation of the changes that these manifestations cause in their interaction